Price $14.67 |
Market Cap
60M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
5.5
|
P/S
200.3
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
33.5
|
Op. Cash Flow
1.7K
|
FCF
0.4
|
|
Op. Margin
-97.30%
|
Net Margin
-
|
ROE
-35.40%
|
ROI
-
|
|
ROA
-27.60%
|
EPS Growth
-109.10%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $3.01 | - | - | 48.7M | Strong Buy |
| Endo International PLC (ENDP) | $5.47 | - | - | 765.3M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $9.48 | - | - | 10.2B | Strong Buy |
| Great Elm Capital Group Inc (GEC) | $2.20 | - | - | 59.3M | Strong Buy |
| Lannett Company, Inc. (LCI) | $7.00 | - | - | 244.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
